Healthcare products
Child Health
Deficiency States and Supplementation
Dermatological Health
Pain treatment
Gastrointestinal Health
Genitourinary Health
Cardiorespiratory Health
Corticotherapy
Oral-Pharyngeal Health
Fluid Therapy
CNS Treatment
Ernodasa, 20 capsules
Ernodasa, 20 capsules
2,50€ IVA Incl.
Estreptodoknassa or Streptodornasa
Enzymatic anti-inflammatory drug, presented in small capsules that can be easilly swallowed. Indicated for the treatment of inflammatory processes in which there are blood acumulations and/or fibrin exudates and purulents.
Composition
| Composition | Per capsule |
|---|---|
| Streptokinase | 10,000 IU |
| Streptodornase | 2,500 IU |
Excipients: Lactose, magnesium stearate, talc, gelatin, titanium dioxide (E-171), indigo carmine (E-132), and azorubine (E-122).
Contraindications
ERNODASA is contraindicated in patients with active hemorrhagic processes or any deficiency in hemostasis. Relative contraindications: Patients at high risk of bleeding (hypertensive, hemiplegic, etc.).
Interactions
Previous treatment with anticoagulants represents a relative incompatibility. The effect of heparin can be blocked with protamine sulfate, administered before treatment with ERNODASA. Similarly, coumarin anticoagulants can be neutralized with vitamin K1 until the Quick value normalizes.
Instructions for Use
Unless otherwise advised by a doctor: 1 capsule every 6 hours for 4 to 6 days. In acute cases, higher doses may be used as an attack therapy. Maximum therapeutic dose: 2 capsules 4 times a day.
Holder
LABORATORIOS ERN, S.A. Perú, 228. 08020 Barcelona, Spain
Prescription drug
NHS funded
- 783993.4 (20 capsules)
